It’s a great idea to invest in us – and here’s why
- Well positioned in secular growth markets: Key growth drivers are Process Solutions, Rare Diseases & Semis
- Strong Cash Generation as backbone for M&A: Maximizing opportunities with active portfolio management
- Resilient in a rapidly changing environment: Multi-industry setup with diversified geographic footprint.
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany Signs Long-term Renewable Energy Contract for ...
Power purchase agreement supports Merck KGaA, Darmstadt, Germany' 2030 sustainability targets to source 80% renewable electricity and reduce Scope 1 and 2 emissions by 50%
2025/11/04
-
Press Releases
MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies ...
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
2025/10/28
-
Press Releases
Global Hackathon by Merck KGaA, Darmstadt, Germany, and Boltz Sets New Benchmark ...
Our global hackathon on protein folding has set a new benchmark for open-source AI-driven innovation in drug development.
2025/10/27
Share Price
Check Share PriceShare Price